NanoHybrids has been awarded $300,000 by the National Cancer Institute of the National Institutes of Health (NIH) to enhance the therapeutic efficacy of photodynamic therapy (PDT) in oral cancers using a novel nano-enabled hybrid technology.
The joint project will involve important in vivo pre-clinical studies designed to validate the efficacy of a nano-enabled platform to raise the therapeutic index of PDT in oral cancer. The nano-enabled hybrid technology’s relevance derives from an ability to enhance potency....
